Table 2 EEF2K expression and correlation with patients’ clinicopathological factors in our cohort
Variable | Positive expression N (%) | Negative expression N (%) | p |
|---|---|---|---|
Age at operation (Mean ± SD) | 68.2 ± 9.7 | 67.4 ± 12.3 | 0.766 |
Gender | |||
Male | 18 (20.7) | 69 (79.3) | 0.589 |
Female | 11 (17.2) | 53 (82.8) | |
Tumor location | |||
Right colon | 11 (25.6) | 32 (74.4) | 0.383 |
Left colon | 3 (12.5) | 21 (87.5) | |
Rectum | 15 (17.9) | 69 (82.1) | |
Tumor grade | |||
Poor | 0 (0) | 5 (100) | 0.584 |
Moderate and well | 29 (19.9) | 117 (80.1) | |
Tumor stage | |||
T1 | 2 (50) | 2 (50) | 0.247 |
T2 | 5 (29.4) | 12 (70.6) | |
T3 | 17 (16.3) | 87 (83.7 | |
T4 | 5 (19.2) | 21 (80.8) | |
Nodal stage | |||
N0 | 21 (24.7) | 64 (75.3) | 0.143 |
N1 | 5 (11.1) | 40 (88.9) | |
N2 | 3 (14.3) | 18 (85.7) | |
Metastasis | |||
No | 27 (19.9) | 109 (80.1) | 0.737 |
Yes | 2 (13.3) | 13 (86.7) | |
Microsatellite instability | |||
Microsatellite stable | 23 (18.9) | 99 (81.1) | 0.690 |
MSI-Low | 2 (22.2) | 7 (77.8) | |
MSI-High | 1 (9.1) | 10 (90.9) | |